New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

Researchers examine survival and cancer recurrence in patients with glottic carcinomas receiving one of two treatments.

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

Michael Green, PhD, discusses a new method of assessing lymphoma subtypes utilizing the tumor microenvironment.

Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have discovered a ...

However, a few modification sites showed cell type specifics. Zhou found that tRNA expressions are largely dysregulated, or altered, in cancerous mammary cell lines compared to the benign cells.

Abnormal amino acid metabolism supports cancer cell proliferation, invasion, and immune evasion in hepatocellular carcinoma (HCC). Previous research exploring amino acid metabolism in HCC has ...

Extensive-stage small-cell lung cancer (ES-SCLC), which accounts for approximately 15% of lung cancers, is an aggressive and highly lethal disease. The current standard of care is induction therapy ...

Abstract Single-cell RNA-sequencing (scRNA-seq) coupled with robust computational analysis facilitates the characterization of phenotypic heterogeneity within tumors. Current scRNA-seq analysis ...

Summary: The authors developed a novel tool, SCellBOW, to perform cell clustering and infer survival risks on individual cancer cell clusters from the single cell RNA seq dataset. The key ...

AbstractActivating mutations in KRAS drive tumorigenesis in pancreatic ductal adenocarcinoma (PDAC), promoting tumor cell proliferation and contributing to an immunosuppressive tumor microenvironment, ...

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...